Angiotech enters distribution pact with B. Braun

Angiotech Pharmaceuticals, a specialty pharmaceutical and medical device company, has entered an exclusive five-year distribution agreement with B. Braun for its proprietary Quill SRS product line in the U.K., Ireland and France. Angiotech release

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.